TrialBone marrow transplantation2022

The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial.

Efthymia Iliana Matthaiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.